We are monitoring the impact of COVID-19 on APAC Theranostics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 5761
Share on
Share on

Asia Pacific Theranostics Market Research Report - Segmented By Disease Type, Technology, End-User & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2021 to 2026)

Pulished: April, 2021
ID: 5761
Pages: 145

APAC Theranostics Market Size (2021 to 2026):

As per the research report, the size of the Asia Pacific Theranostics Market is estimated to grow at a healthy CAGR during the forecast period. Theranostics is a combination of drug therapy and diagnostics.

The growing occurrence rate of cancer and the large patient pool is a significant factor fueling the market. Funds and investments from government and other healthcare organizations towards the research and development in drug synthesis to deal with new and killing diseases are propelling the theranostics market growth during the period. People who are more prone to suffer from diseases like various kinds of cancer and other chronic ailments is expected to drive the theranostics market in this region. FDA approvals for new drug discovery and diagnostics procedures and the devices used for diagnosing are expected to spur the market growth over the period. Mergers, partnerships, and collaborations by the key players for manufacturing in developing new companion diagnostics are to surge the theranostics market over the forecasting framework.

Cost related to the therapy and diagnostics is so expensive, which is the primary factor restraining the market growth over the analysis period. Moreover, strict regulatory frameworks for the product approvals and also drug discovery are limiting the market growth in this region. Also, the lack of awareness among the patients regarding the diagnosis of the diseases and the therapy related to the disorders may impede the market negatively.

This research report on the APAC Theranostics Market has been segmented and sub-segmented into the following categories:

By Disease Type:

  • Neurological Disorders
  • Cardiovascular Diseases
  • Immunological Disorders
  • Oncology
  • Others

By Technology:

  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry
  • In Situ Hybridization
  • Sequencing
  • Others

By End-User:

  • Hospitals
  • Diagnostics Laboratories
  • Others

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

China holds a significant share in the market due to the presence of market leaders as well as developed healthcare and pharmaceutical infrastructure. India is the fastest-growing region due to increasing expenditure on health care, product innovation, and rising disposable income. Based on Disease Type, Neurological disorders are the holding the significant share in the market due to prevalence of diseases like Parkinson’s Disease, Alzheimer’s Disease and other prevalent diseases, meanwhile, cancer diseases and cardiovascular disorders are expected to grow the fastest due to increasing risk rate and prevalence of these diseases and increasing research expenditure by pharmaceutical companies.

Top companies leading in the APAC Theranostics Market profiled in the report are Abbott Laboratories, AmeriPath, Dickinson and Company, BIOTEC Laboratories, Dade Behring, Dianon Systems, Dynacare Laboratories, Enterix, Focus Diagnostics, Pfizer and Beckman Coulter.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods   

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Disease Type                                             

                                5.1.1 Introduction                           

                                5.1.2 Neurological Disorders                       

                                5.1.3 Cardiovascular Diseases                    

                                5.1.4 Cancers                    

                                5.1.5 Others                      

                                5.1.6  Y-o-Y Growth Analysis, By Disease Type                    

                                5.1.7  Market Attractiveness Analysis, By Disease Type                  

                                5.1.8  Market Share Analysis, By Disease Type     

               5.2 By Technology                                         

                                5.2.1 Introduction                           

                                5.2.2 Polymerase Chain Reaction (PCR)                       

                                5.2.3 Immunohistochemistry

                                5.2.4 In Situ Hybridization                  

                                5.2.5 Sequencing                    

                                5.2.6 Others                      

                                5.2.7 Y-o-Y Growth Analysis, By Technology            

                                5.2.8 Market Attractiveness Analysis, By Technology           

                                5.2.9 Market Share Analysis, By Technology       

               5.3 By End User

                                5.3.1 Hospitals                           

                                5.3.2 Diagnostics Laboratories                    

                                5.3.3 Others                  

                                5.3.4 Y-o-Y Growth Analysis, By End User            

                                5.3.5 Market Attractiveness Analysis, By End User           

                                5.3.6 Market Share Analysis, By End User                 

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                       By Geographical Area     

                                       By Disease Type

                                       By Technology

                                       By End User

                                6.1.4  Market Attractiveness Analysis                     

                                       By Geographical Area     

                                       By Disease Type

                                       By Technology

                                       By End User

                                6.1.5  Market Share Analysis                      

                                       By Geographical Area     

                                       By Disease Type

                                       By Technology

                                       By End User

                6.2 China                                             

                6.3 India                                              

                6.4 Japan                                            

                6.5 South Korea                                               

                6.6 Australia                                      

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8. Market Leaders' Analysis                                                        

                8.1 Abbott Laboratories                                               

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 AmeriPath                                  

                8.3 Dickinson and Company                                        

                8.4 BIOTEC Laboratories                                               

                8.5 Dade Behring                                             

                8.6 Dianon Systems                                        

                8.7 Dynacare Laboratories                                           

                8.8 Enterix                                          

                8.9 Focus Diagnostics                                     

                8.10 Pfizer                                          

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10. Market Outlook and Investment Opportunities                                                         


                a) List of Tables                                

                b) List of Figures                                              

  • Asia pacific and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Region, by Diseases along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market


  1. Asia Pacific Theranostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  2. Asia Pacific Neurological Disorders Market, By Region, From 2021 to 2026 (USD Million)
  3. Asia Pacific Cardivascular Disorders Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia Pacific Cancers Market, By Region, From 2021 to 2026 (USD Million)
  5. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Million)
  6. Japan Theranostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  7. China Theranostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  8. India Theranostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  9. Australia Theranostics Market, By Disease Type, From 2021 to 2026 (USD Million)
  10. South Korea Theranostics Market, By Disease Type, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports


$ 1234 3335

Click for Request Sample